Projects funded by the NCN
Hydantoin derivatives in a fight with drug resistance of bacteria
2013/09/N/NZ7/02085
Keywords:
multidrug resistance bacteria Staphylococcus aureus MRSA
Descriptors:
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
- NZ1_10: Microbiology
- NZ2_10: Biological systems analysis, modelling and simulation
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Uniwersytet Jagielloński - Collegium Medicum, Collegium Medicum, Wydział Farmaceutyczny
woj. małopolskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 3
Call: PRELUDIUM 5 - announced on 2013-03-15
Amount awarded: 49 999 PLN
Project start date (Y-m-d): 2014-05-05
Project end date (Y-m-d): 2015-05-04
Project duration:: 12 months (the same as in the proposal)
Project status: Project settled
Information in the final report
- Publication in academic press/journals (1)
- Imidazolidine-4-one derivatives in the search for novel chemosensitizers of S. aureus MRSA: synthesis, biological evaluation and molecular modeling studiesAuthors:Anna Matys, Sabina Smusz, Karolina Witek, Jagna Witek, Andrzej J. Bojarski, Jakub Schabikowski, Ewa Otrębska-Machaj, Gniewomir Latacz, Ewa Szymańska, Katarzyna Kieć- Kononowicz, Joseph Molnar, Leonard Amaral, Jadwiga HandzlikAcademic press:European Journal of Medicinal Chemistry (rok: 2015, tom: 101, strony: 313-325), Wydawca: ElsevierStatus:PublishedDOI:10.1016/j.ejmech.2015.06.013 - link to the publication